Christopher B. Prentiss
2019
In 2019, Christopher B. Prentiss earned a total compensation of $1.1M as Chief Financial Officer at Adamas Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $184,000 |
|---|---|
| Option Awards | $298,980 |
| Salary | $358,333 |
| Stock Awards | $245,188 |
| Other | $7,140 |
| Total | $1,093,641 |
Prentiss received $358.3K in salary, accounting for 33% of the total pay in 2019.
Prentiss also received $184K in non-equity incentive plan, $299K in option awards, $245.2K in stock awards and $7.1K in other compensation.
Rankings
In 2019, Christopher B. Prentiss' compensation ranked 8,870th out of 13,971 executives tracked by ExecPay. In other words, Prentiss earned more than 36.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,870 out of 13,971 | 37th |
Division Manufacturing | 3,537 out of 5,695 | 38th |
Major group Chemicals And Allied Products | 1,337 out of 2,194 | 39th |
Industry group Drugs | 1,138 out of 1,880 | 40th |
Industry Pharmaceutical Preparations | 842 out of 1,392 | 40th |
Source: SEC filing on April 23, 2020.
Prentiss' colleagues
We found three more compensation records of executives who worked with Christopher B. Prentiss at Adamas Pharmaceuticals in 2019.